Literature DB >> 19302992

Laboratory safety and the WHO World Alliance for Patient Safety.

Layla McCay1, Claire Lemer, Albert W Wu.   

Abstract

Laboratory medicine has been a pioneer in the field of patient safety; indeed, the College of American Pathology first called attention to the issue in 1946. Delivering reliable laboratory results has long been considered a priority, as the data produced in laboratory medicine have the potential to critically influence individual patients' diagnosis and management. Until recently, most attention on laboratory safety has focused on the analytic stage of laboratory medicine. Addressing this stage has led to significant and impressive improvements in the areas over which laboratories have direct control. However, recent data demonstrate that pre- and post-analytical phases are at least as vulnerable to errors; to further improve patient safety in laboratory medicine, attention must now be focused on the pre- and post-analytic phases, and the concept of patient safety as a multi-disciplinary, multi-stage and multi-system concept better understood. The World Alliance for Patient Safety (WAPS) supports improvement of patient safety globally and provides a potential framework for considering the total testing process.

Entities:  

Mesh:

Year:  2009        PMID: 19302992     DOI: 10.1016/j.cca.2009.03.019

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

1.  Role of intervention on laboratory performance: evaluation of quality indicators in a tertiary care hospital.

Authors:  Rachna Agarwal; Sujata Chaturvedi; Neelam Chhillar; Renu Goyal; Ishita Pant; Chandra B Tripathi
Journal:  Indian J Clin Biochem       Date:  2012-01-07

2.  Impact of the phlebotomy training based on CLSI/NCCLS H03-a6 - procedures for the collection of diagnostic blood specimens by venipuncture.

Authors:  Gabriel Lima-Oliveira; Giuseppe Lippi; Gian Luca Salvagno; Martina Montagnana; Geraldo Picheth; Gian Cesare Guidi
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.